Medical Management of Pulmonary Nontuberculous Mycobacterial Disease

Julie V Philley; David E Griffith

doi:10.1016/j.thorsurg.2018.09.001

Medical Management of Pulmonary Nontuberculous Mycobacterial Disease

Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001.

Authors

Julie V Philley¹, David E Griffith²

Affiliations

¹ Pulmonary and Critical Care Medicine, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA. Electronic address: Julie.Philley@uthct.edu.
² Pulmonary and Critical Care Medicine, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.

PMID: 30454923
DOI: 10.1016/j.thorsurg.2018.09.001

Abstract

Nontuberculous mycobacterial (NTM) lung infections are increasingly recognized as a cause of chronic pulmonary disease. This article focuses on the most common NTM species known to cause human lung disease and the treatment options currently available. The diagnosis of NTM lung disease is also discussed, emphasizing the necessity for treating clinicians to have sufficient familiarity of the mycobacteria laboratory to provide optimal patient management.

Keywords: Abcsessus; MAC; Mycobacteria; NTM; Nontuberculous.

Publication types

Review

MeSH terms

Antitubercular Agents / therapeutic use
Humans
Lung Diseases / diagnosis
Lung Diseases / drug therapy*
Lung Diseases / therapy
Mycobacterium Infections, Nontuberculous / diagnosis
Mycobacterium Infections, Nontuberculous / drug therapy*
Mycobacterium Infections, Nontuberculous / therapy
Nontuberculous Mycobacteria / isolation & purification*

Substances

Antitubercular Agents